Home > Insider Trading > Filing (0000899243-20-005986)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
896262	Amedisys Inc	AMED	Services-Home Health Care Services (8082)	113131700

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1673554	L David Kemmerly	3854 American Way, Suite A Baton Rouge LA 70816	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-02-24	725	$127.11	21,455	No	4	M	Direct
Common Stock	Disposition	2020-02-24	725	$186.87	20,730	No	4	S	Direct
Common Stock	Disposition	2020-02-24	391	$186.87	20,339	No	4	S	Direct
Common Stock	Disposition	2020-02-25	202	$191.88	20,137	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2020-02-24	725	$0.00	725	$127.11

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,173		2029-02-20	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	506	Indirect	Through 401(k) Plan

Footnotes

The total amount of shares beneficially owned includes 246 shares held in an employee stock purchase plan account.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
The information in this report is based on a plan statement dated as of December 31, 2019.
On February 20, 2019, the reporting person was granted an option to purchase 2,898 shares of common stock. The option is subject to time-based vesting conditions. The option vested as to 725 shares on February 20, 2020, and the remaining 2,173 will vest in equal installments on each of February 20, 2021, 2022 and 2023, provided that the reporting person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the stock option.